Single vs Double Embryo Transfer (SET)

This study has been terminated.
(Change in cryopreservation protocol)
Sponsor:
Information provided by (Responsible Party):
Manuel Fernandez, Instituto Valenciano de Infertilidad, Spain
ClinicalTrials.gov Identifier:
NCT00814398
First received: December 23, 2008
Last updated: April 22, 2013
Last verified: March 2011
  Purpose

The aim of this project is to study the best number (1 or 2)and day (3 vs 5)of embryo transfer in good prognosis patient.


Condition Intervention
Infertility
Procedure: 2 embryos transfer
Procedure: 1 embryo transfer

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Single vs Double Embryo Transfer in Day 3 or Blastocyst Stage

Resource links provided by NLM:


Further study details as provided by Instituto Valenciano de Infertilidad, IVI VALENCIA:

Primary Outcome Measures:
  • Live-birth delivery rate [ Time Frame: End of pregnancy (nine months after last transfer) ] [ Designated as safety issue: No ]
  • Multiple live-birth rate [ Time Frame: End of pregnancy (nine months after last transfer) ] [ Designated as safety issue: No ]
  • Acceptance of assigned randomised group [ Time Frame: Day of randomisation ] [ Designated as safety issue: No ]

Enrollment: 199
Study Start Date: December 2008
Study Completion Date: September 2009
Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
Single embryo transfer on day 3 of embryo development
Procedure: 1 embryo transfer
1 embryo
Experimental: 2
2 embryos on day 3
Procedure: 2 embryos transfer
2 embryos
Experimental: 3
1 embryo on day 5
Procedure: 1 embryo transfer
1 embryo
Experimental: 4
2 embryos on day 5
Procedure: 2 embryos transfer
2 embryos

  Eligibility

Ages Eligible for Study:   18 Years to 37 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:G

  • Good prognosis IVF patients

Exclusion Criteria:

  • Bad prognosis IVF patients
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00814398

Locations
Spain
IVI-Sevilla
Seville, Spain, 41011
Sponsors and Collaborators
Instituto Valenciano de Infertilidad, IVI VALENCIA
Investigators
Principal Investigator: Manuel Fernandez, MD IVI Sevilla
  More Information

No publications provided

Responsible Party: Manuel Fernandez, Primary Investigator, Instituto Valenciano de Infertilidad, Spain
ClinicalTrials.gov Identifier: NCT00814398     History of Changes
Other Study ID Numbers: IVISEV-002SET
Study First Received: December 23, 2008
Last Updated: April 22, 2013
Health Authority: Spain: Ministry of Health

Keywords provided by Instituto Valenciano de Infertilidad, IVI VALENCIA:
Infertility
IVF
SET
DET
Blastocyst

Additional relevant MeSH terms:
Infertility
Genital Diseases, Male
Genital Diseases, Female

ClinicalTrials.gov processed this record on August 20, 2014